EP2552452
EGFR inhibitor and antiviral agent for simultaneous, separate or sequential use in the treatment and/or prevention and/or palliation of cancer
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
24.3.2011EP published:
19.8.2015EP application number:
11709746.9
EPO information:
European Patent Register
Max expiry date:
23.3.2031
Title:
EGFR inhibitor and antiviral agent for simultaneous, separate or sequential use in the treatment and/or prevention and/or palliation of cancer
Timeline
Today
24.3.2011EP application
19.8.2015EP Publication
Owner
Name:
Institut Gustave Roussy (IGR)Address:
39, rue Camille Desmoulins, 94800, Villejuif, FR
Name:
Université Paris-Sud 11Address:
15, rue Georges Clémenceau, 91405, Orsay Cedex, FR
Inventor
Name:
DEUTSCH, EricAddress:
Paris, FR
Name:
VOZENIN, Marie CatherineAddress:
Villeneuve Sur Auvers, FR
Name:
BOURHIS, JeanAddress:
Sceaux, FR
Priority
Number:
10290177Date:
1.4.2010Country:
EP
Classification
Categories:
A61K 31/675, A61K 45/06, A61K 31/517, A61K 31/522, A61K 31/662, A61K 39/395, A61P 35/00